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one marrow-derived precursor cells that commit to the ␣␤ T lineage express a pre-TCR composed of a nonrearranging pre-T␣ protein and the rearranged TCR␤-chain (1) (2) (3) . Signaling through the pre-TCR elicits multiple cellular responses that include cell survival, proliferation, down-regulation of pre-T␣ and CD25 expression, up-regulation of sterile TCR␣ transcript, and initiation of rearrangement at the TCR␣ locus (4 -7). Pre-TCR induced proliferation ensures the expansion of CD4 Ϫ CD8 Ϫ double negative (DN) 3 clones expressing competent TCR␤-chain before maturation to the CD4 ϩ CD8 ϩ double positive (DP) stage of development (8) . At the DP stage rearrangement of TCR␣-chain requires re-expression of RAG2 protein, which is only expressed in growth arrested cells (9, 10) . TCR␣-chain rearrangement and expression leads to the expression of ␣␤TCR. DP thymocytes expressing ␣␤TCR are subject to positive and negative selection to ensure self-restriction and avoid autoimmunity (11) (12) (13) (14) (15) .
Pre-TCR signals target several nuclear factors including E proteins, NF-B, NFAT, T cell factor (TCF)-1, and the early growth response (Egr) proteins (16 -21) . Egr proteins have been shown to be effectors of pre-TCR signals (19, 22) . Egr1, 2, and 3 are all expressed during thymocyte development and induced in response to pre-TCR signaling. Over-expression of Egr proteins in pre-TCR signaling deficient thymocytes facilitates transition through the ␤-selection checkpoint while expression of dominant negative Egr proteins inhibits transition of DN3 thymocytes to the DN4 or pre-DP stage. Moreover, Egr3 deficient mice show a partial block at the DN3 stage of development (19, 22, 23) . Thus, Egr proteins are targets of pre-TCR signaling and regulate several essential aspects of ␤-selection checkpoint.
␤-catenin is a central mediator of Wnt-␤-catenin-TCF signaling pathway. In the absence of Wnt-ligand binding to Frizzled receptor, GSK-3␤ phosphorylates ␤-catenin targeting it to the ubiquitin-dependent degradation pathway (24) . Wnt signals block GSK-3␤ activity thereby stabilizing ␤-catenin, which then translocates to the nucleus and interacts with TCF and lymphocyte enhancer binding factor (LEF) to promote gene transcription (25) (26) (27) (28) . This signaling pathway has been implicated in T cell development by several studies. LEF and TCF double deficiency leads to a block in thymocyte development at the DN3 stage, in addition to a complete block at the immature single positive stage (29 -31) . Accordingly, we have reported that T cell-specific deletion of ␤-catenin impairs ␤-selection (32) . Interestingly, over-expression of ␤-catenin facilitates the maturation of DN thymocytes to the DP stage, without the expression of pre-TCR or the TCR␤-chain, suggesting that ␤-catenin over-expression substitutes for ␤-selection signals (33) . Thus, the phenotype of thymocytes over-expressing ␤-catenin complements the observations noted in T cell specific deletion of ␤-catenin (32) . These data suggest that ␤-catenin stabilization is necessary and sufficient for the transition of DN thymocytes to the DP stage. Accordingly, Wnt1 and Wnt4 deficiency (34) , or blocking Wnt signaling by expression of extracellular inhibitors, modified Frizzled receptors (35) or Dickkopf (36) or intracellular inhibitors Axin (37) or ICAT (38) all impaired early stages of thymocyte development, indicating the importance of Wnt-␤-catenin-TCF signaling. Despite these data, the role of ␤-catenin in lymphocytes remains controversial in large measure due to three reports that showed that deletion of ␤-catenin in HSCs did not impair hematopoiesis or lymphopoiesis (39 -41) , even though Jeannet et al. demonstrated that TCF-reporter activity was measurable in all HSC-derived cells suggesting that signaling from this pathway remained intact in their studies (41) . In summary, whereas a substantial body of work suggests ␤-catenin plays an important role in lymphocyte development contradictions presented by more recent work warrant clarification.
In this report, we demonstrate that pre-TCR signals transiently stabilize ␤-catenin in DN thymocytes and facilitate transition through ␤-selection. Pre-TCR signaling induces stabilization of ␤-catenin by an Erk-dependent pathway. Enforced expression of stabilized ␤-catenin was sufficient to mediate down-regulation of cell surface CD25 expression, pre-T␣ expression and induce expression of Egr genes and sterile TCR␣ transcript. Using mice that express a stabilized ␤-catenin transgene (CAT-Tg), and mice that are deficient for ␤-catenin (CAT-KO), we demonstrate that pre-TCR induced ␤-catenin regulates the expression of Egr genes that critically control transition of DN cells to the DP stage of development. Finally, we demonstrate that ␤-catenin is bound to the regulatory region of Egr genes and directly regulates their expression.
Materials and Methods

Mouse strains
CAT-Tg mice and CAT-KO mice, generated by crossing mice bearing loxed ␤-catenin gene (The Jackson Laboratory) (42) with Lck-Cre mice (43) all on C57BL/6 genetic background were described previously (44, 45) . RAG2-deficient mice and BAT-lacZ mice (46) were purchased from The Jackson Laboratory. Egr3 transgenic mice were generated using the VA-hCD2 vector, which directs transgene expression in T cells beginning with DN2/3 stage thymocytes (47, 48 ). An Egr3 cDNA encompassing the translational start and stop codons was generated by PCR, sequence verified, subcloned into VA-hCD2 using standard methodology, and injected by the Fox Chase Transgenic Mouse Facility. Founders were bred to RAG2 Ϫ/Ϫ mice. Where not specified, agematched 6 -12-wk-old mice were used. All animal procedures were in compliance with the guidelines of NIA animal resources facility, which operates under the regulatory requirements of the U.S. Department of Agriculture and Association for Assessment and Accreditation of Laboratory Animal Care.
Cell lines and in vitro cell culture
Scid.adh cells have been described (4) . Scid.adh.Te3 cells are Scid.adh cells transfected with TAC:CD3 chimera, which can be stimulated by anti-TAC Ab, to mimic pre-TCR signaling (4). In brief, 0.5-1 ϫ 10 6 Scid.adh.Te3 cells were stimulated by plate-bound anti-TAC Ab (10 g/ ml) at 37°C in 1 ml RPMI 1640 in 24-well tissue culture plates.
Flow cytometry and Abs
Four-color flow cytometry was done using FACScalibur (BD Pharmingen) following staining with combination of anti-CD3, -CD4, -CD8, -c-kit, -CD44, -CD25, -CD5, -IL-7R Abs conjugated to FITC, PE, PercpCy5.5, allophycocyanin (BD Pharmingen). Lineage mixture contained Abs to CD4, CD8, TCR␤, TCR␥␦, B220, NK1.1, Gr1, and Mac-1. For cell sorting, cell suspensions of thymocytes were stained with biotinylated anti-CD4 and anti-CD8 Abs, followed by incubation with anti-biotin microbeads (Miltenyi Biotec) and magnetic depletion of DP and single positive cells. Enriched cell suspensions were surface-stained with anti-CD25, anti-c-kit and lineage Ab mixture followed by sorting using MoFlo.
Quantitative and semiquantitative PCR
mRNA from sorted cells was extracted with RNeasyMicro Kit (Qiagen). cDNA was prepared with Superscript II RT kit (Invitrogen). SYBR green quantitative RT-PCR was performed using PCR Master Mix from A&B Applied Biosystem following the manufacturer's instructions. The expression of target gene was determined relative to GAPDH and calculated as 2 Ϫ(CtTarget gene Ϫ CtGAPDH) . All the primer sequences are available upon request.
Western blot analysis
Immunoblotting was performed with whole-cell lysates or nuclear extracts resolved on 4 -12% Bis-Tris SDS-PAGE, transferred to nitrocellulose membrane and detected using Abs against mouse ␤-catenin (BD Transduction Laboratory), anti-active-␤-catenin (anti-ABC, clone 8E7) (Upstate Biotechnology), mouse ␤-actin (Sigma-Aldrich), and nucleoporin p62 (BD Transduction Laboratory).
Chromatin immunoprecipitation (ChIP) assays
ChIP procedure was performed with nuclear extracts from 12 h anti-TAC treated and untreated 5-10 ϫ 10 6 Scid.adh.Te3 cells fixed with 1% formaldehyde. Sonicated nuclear lysates were immunoprecipitaed with either anti-␤-catenin Ab or rabbit IgG (Santa Cruz Biotechnology). After purification of DNA coprecipitated with Abs DNA encompassing putative TCF binding sites in Egr1, Egr2, and Egr3 genes was amplified using specific primers by quantitative real-time PCR. An irrelevant region 5-kb downstream of Egr1, Egr2, and Egr3 transcription start site was amplified as a control. All primers are available upon request.
EMSAs
EMSAs were conducted with 2 ng of 32 P-labeled oligonucleotide DNA probes (40 -50000 c.p.m.) in a final reaction volume of 15 l containing 10 mM Tris-HCl (pH 7.5), 50 ng poly (dI-dC), 50 mM NaCl, 10 mM 2-ME, 1 mM EDTA, and 4% glycerol for 30 min at 4°C. Reactions were resolved on a 6% polyacrylamide gel. A partially purified LEF1 protein preparation was used (generous gift from Dr. Marian Waterman, University of California, Irvine, CA). The positive control oligos encode a consensus Wnt response element (49) . The putative TCF/LEF binding sites identified in Egr1, 2, and 3 genes are listed: Egr1 sense: 5Јgaatcccttctccctttgggttgctt 3Ј, anti-sense: 5Јgaagcaacccaaagggagaagggatt 3Ј; Egr2 sense: 5Јgaactgggagg cccctttgaccagatgaa 3Ј, anti-sense: 5Јgttcatctggtcaaaggggcctcccagtt 3Ј; Egr3 sense: 5Јgaaccccttccccaaaggaaaatactt 3Ј, anti-sense: 5Јgaagtattttcctttggg gaaggggtt 3Ј.
Retroviral infection
Scid.adh cells were infected with murine stem cell virus-based retroviruses that coexpress human CD8 and stabilized mouse ␤-catenin. Human CD8 positive cells were sorted for analysis.
Results
Pre-TCR induces stabilization and nuclear localization of ␤-catenin via ERK activation
To test whether ␤-catenin is a target of pre-TCR signaling, we used a well-established model in which anti-CD3 Ab injection mediates differentiation of RAG2-deficient DN3 thymocytes to the DN4/ pre-DP stage of development (50) . In a time course study, at 18 h after anti-CD3 Ab injection, 60 -70% thymocytes were still at the DN3 stage while 30 -40% had differentiated to the DN4 stage (Fig.  1A) . Egr genes are early indicators of pre-TCR signal and induction of their expression by 12-h post anti-CD3 Ab injection suggested that DN cells had received a pre-TCR-like signal (Fig. 1A) . Under these conditions a 2.5-fold increase in stabilized ␤-catenin was documented in four independent Western blot experiments (Fig. 1A) . These data show that the level of pre-TCR induced stabilization of ␤-catenin is comparable to 2-fold ␤-catenin accumulation in stimulated macrophages, B cells, and T cells (32, 51, 52) . Thus, these data demonstrate that the anti-CD3 Ab dependent pre-TCR signal, which induces the development of RAG2-deficient DN3 thymocytes to the DN4 stage in vivo, stabilizes ␤-catenin protein levels and suggest that ␤-catenin may be a direct target of pre-TCR signals.
To demonstrate that pre-TCR signals induced ␤-catenin-TCF signaling, we used BAT-lacZ transgenic mice that express the lacZ gene under the control of a regulatory sequence consisting of seven consensus LEF/TCF-binding motifs upstream of the Xenopus siamois gene minimal promoter (46) . Thus, ␤-galactosidase expression reports TCF activity in vivo. Purified DN thymocytes from BAT-lacZ or control mice were stimulated with plate-bound anti-CD3 Ab for indicated times to induce pre-TCR signaling and mRNA extracted from them were analyzed by real-time PCR for ␤-galactosidase expression. After 6 and 24 h of anti-CD3 stimulation, BAT-lacZ DN cells up-regulated ␤-galactosidase expression relative to the control mice DN cells and to unstimulated BAT-lacZ DN cells (Fig. 1B) . These data suggest that ␤-catenin/TCF activity was induced by pre-TCR signaling.
Ab-mediated cross-linking of CD3-chain on RAG2-deficient thymocytes regulates ␤-catenin stabilization and transition of the DN3 cells to the DN4/pre-DP stage demonstrating that pre-TCR signals induce ␤-catenin expression. To test whether pre-TCR signals directly induce ␤-catenin stabilization we used the Scid.adh cell line in vitro. The Scid.adh.Te3 cell line lacks endogenous TCR␤-chain expression but expresses transfected human CD25 (hCD25)-CD3 chimeric protein. Cross-linking of hCD25-CD3 on the surface of Scid.adh.Te3 cell line with anti-TAC Ab has been shown to mimic several molecular aspects of ␤-selection (4, 19) . As has been previously documented, cross-linking cell surface hCD25-CD3 with anti-TAC Ab induced pre-TCR like signals that extinguished the expression of murine CD25 and partially upregulated expression of CD5 (Fig. 1C) . Under these conditions, ␤-catenin accumulation in the nucleus of signaled cells was documented by Western blots using nuclear extracts (Fig. 1D, left) . An ϳ2-fold increase in the amount of ␤-catenin protein accumulation was noted in three independent experiments. Pre-TCR signaling induced activation of ERK is essential for CD25 down-regulation (53) . To determine whether ERK may be an intermediate between the pre-TCR signal and ␤-catenin stabilization we used PD98059, an inhibitor of ERK activation. Inclusion of PD98059 in the cultures during anti-TAC cross-linking blocked the down-regulation of CD25 and accumulation of ␤-catenin in the nucleus demonstrating that TAC-induced nuclear ␤-catenin accumulation was ERK dependent (Fig. 1D ). These data demonstrate that in Scid.adh cells pre-TCR signals, via the activation of ERK signaling, directly induce the stabilization and nuclear localization of ␤-catenin.
␤-catenin expression is sufficient to regulate Egr expression during ␤-selection
Several molecular events that accompany ␤-selection in vivo are mimicked in the Scid.adh.Te3 cell line by cross-linking of the hCD25-CD3 chimeric protein using anti-TAC Ab (this report and Ref. 4, 19) . To determine which of the events were regulated by ␤-catenin stabilization we expressed stabilized ␤-catenin gene in Scid.adh cells using a retroviral vector. In a population of Scid.adh cells with Ͼ70% infection efficiency (data not shown), we noted dramatic down-regulation of CD25 and up-regulation of IL-7R␣-chain ( Fig. 2A) . To assess molecular changes enforced by ␤-catenin expression retrovirally infected cells were sorted and RNA was prepared. At a molecular level pre-T␣ gene expression was significantly diminished whereas expression of sterile TCR␣ transcript, Egr1 and Egr2 genes were increased (Fig. 2B) . High expression of Egr3 in Scid.adh cells precluded analysis of its induction by ␤-catenin (data not shown). These observations indicate that expression of ␤-catenin in the Scid.adh cells reproduces the effects of cross-linking the hCD25-CD3 chimera (4, 19) . Together these data demonstrate that enforced expression of stabilized ␤-catenin in Scid.adh cells mimicked events that normally accompany pre-TCR signals. We conclude that stabilized ␤-catenin was sufficient to partially induce traversal through the ␤-selection checkpoint.
␤-catenin expression regulates Egr gene expression in vivo
We have previously reported that tissue-specific deletion of ␤-catenin in DN3 cells impairs ␤-selection (32). In CAT-KO mice the gene is deleted partially in DN3 cells and more dramatically in DN4 cells (Fig. 3A) . The Lck promoter activity has been documented in DN2 cells, however for reasons not yet understood, Lck-Cre was not active in CAT-KO DN2 cells (data not shown). To determine the effect of ␤-catenin deletion on Egr gene expression, mRNA from sorted CAT-KO DN3 and DN4 cells was analyzed. The abundance of mRNA for Egr family genes was comparable in CAT-KO and control mice DN3 cells (Fig. 3B) , this is because deletion of ␤-catenin is partial in CAT-KO DN3 thymocytes. Pre-TCR signaling induced the expression of Egr1 and Egr3 genes and to a lesser extent Egr2 gene (Fig. 3B) . However, expression of all three Egr genes was decreased in CAT-KO DN4 cells (Fig. 3B) . Expression of Egr genes was not completely abrogated in CAT-KO DN4 cells indicating that additional factors regulate these genes. Egr 2 and 3 genes showed the greatest decrease in CAT-KO DN4 cells. These data demonstrate that pre-TCR induced ␤-catenin was necessary for efficient expression of Egr genes in DN4 thymocytes during T cell development.
CAT-Tg mice express stabilized human ␤-catenin gene from the proximal Lck promoter (44) . The mRNA for the transgene was not expressed in DN2 cells (54) , expressed at low levels in sorted DN3 cells, and expressed at high levels in DN4 cells (Fig. 3C) . Increase in ␤-catenin mRNA level led to increased expression of the protein in DN4 cells (data not shown). Expression of Egr genes was comparable in control and CAT-Tg DN3 cells but increased in CAT-Tg DN4 cells compared with control DN4 cells (Fig. 3D ). These data demonstrate that expression of transgenic ␤-catenin in DN4 cells was sufficient to induce expression of Egr genes. Together these data suggest that pre-TCR induced ␤-catenin regulates expression of Egr genes during ␤-selection in vivo.
Enforced expression of Egr3 facilitates traversal through ␤-selection
To determine whether Egr expression down-stream of pre-TCR was sufficient to regulate ␤-selection, we used RAG2KO-Egr3-Tg mice. Enforced expression of Egr3 transgene, from the CD2 promoter, promoted the development of RAG2-deficient DN3 thymocytes to the DN4 stage and subsequently to the DP stage of development (Fig. 4 ). These data demonstrate that Egr3 expression was sufficient to facilitate ␤-selection in RAG2-deficient DN3 cells. We conclude that pre-TCR induced ␤-catenin results in increased Egr gene expression which facilitates ␤-selection.
␤-catenin associates with the TCF binding sites in Egr promoter region
␤-catenin regulates gene expression in conjunction with TCF which contacts DNA directly. Transcription factors of the TCF family bind DNA via the 80 amino acid HMG box to a consensus sequence AACAAAG through contacts made predominantly within the minor groove of the DNA helix (55, 56) . To test whether ␤-catenin, in cooperation with TCF, directly regulated Egr expression, we searched mouse Egr1, 2, 3 genes for the core consensus sequence (CAAAGG) of TCF binding sites. All three Egr genes contained matches to consensus TCF/LEF binding sites that were conserved in human and murine Egr genes (Fig. 5A) . Thus, all three Egr genes have conserved sequences containing potential TCF/LEF binding sites.
To determine whether TCF binding sites in Egr genes could bind TCF/LEF family proteins we did EMSAs with purified LEF protein and oligonucleotides containing the TCF/LEF binding sites from the Egr genes. LEF protein formed a DNA protein complex with labeled oligonucleotides corresponding to TCF binding sites from all three Egr genes (Fig. 5B ). These results demonstrate that TCF/LEF binding sites in the regulatory regions of Egr1, Egr2, and Egr3 genes are capable of binding TCF/LEF family proteins.
Specific primers for ChIP assays containing TCF/LEF binding sites in Egr1, Egr2, and Egr3 genes and nonspecific primers corresponding to a DNA sequence several kilo-bases downstream (Egr-downstream) were designed. Scid.adh.Te3 cells were stimulated with anti-TAC Ab for 12 h and analyzed for expression of Egr mRNA. Anti-TAC Ab stimulation did induce transcription of Egr genes (Fig. 5C ) as also previously shown (4). To determine whether ␤-catenin bound to the Egr regulatory region we compared unstimulated and anti-TAC-stimulated cells by ChIP analysis (Fig. 5D) . We used DNA templates that were not subjected to immunoprecipitation (input) as normalizing control. PCR was then performed using the DNA coimmunoprecipitated by anti-␤-catenin Ab or control rabbit IgG Ab (Fig. 5D ). Control nonspecific primers from a site 5 kb downstream from the transcription start site did not show any enrichment of specific DNA sequences in the anti-␤-catenin Ab precipitates (data not shown). In contrast, immunoprecipitates with anti-␤-catenin Ab were enriched for sequences containing TCF binding sites in all three Egr genes in stimulation conditions compared with resting cells or to immunoprecipitates with control rabbit IgG Ab (Fig. 5D ). These data demonstrate that ␤-catenin was bound to DNA sequences that had the TCF/LEF binding sites in Egr genes. We conclude that TCF/LEF-␤-catenin complexes bound to regulatory elements in Egr gene loci and directly regulated expression of Egr genes upon pre-TCR signaling.
Discussion
The role for Wnt-␤-catenin-TCF pathway in T cell development remains highly controversial despite the demonstration that Wnt1 and Wnt4 deficiency (34), ␤-catenin deficiency (32) and TCF and LEF deficiencies (29, 30) impair T cell development. This is largely due to a lack of a lymphoid phenotype in mice with Mx1-cre dependent deletion of ␤-catenin (recently reviewed in Ref. 57 ). Although we are unable to solve the entire mystery of lack of phenotype in Mx1-cre deleted mice we provide molecular evidence to support a role for ␤-catenin at the ␤-selection checkpoint. We have previously shown that T cell specific deletion of ␤-catenin impairs ␤-selection (32) . In this report, we provide molecular data that reinforces the importance of this pathway during ␤-selection. We demonstrate that pre-TCR induced ␤-catenin directly regulates the expression of Egr genes which are necessary and sufficient for traversal through ␤-selection.
We have reported that even partial deletion of ␤-catenin in DN3 cells results in a partial block in development at the DN3 stage (32) . Conversely, enforced expression of ␤-catenin, correlates with an increased proportion of post-␤-selection cells (data not shown). These data raise the possibility that the pre-TCR may regulate ␤-catenin stabilization. In this report, using a well defined in vivo model, we demonstrate that pre-TCR signals stabilize and induce nuclear localization of ␤-catenin. Injection of anti-CD3 Ab in RAG2-deficient mice induced the differentiation of DN3 cells to the DN4 stage and induced Egr gene expression indicating traversal through ␤-selection. After 18 h of exposure to anti-CD3 Ab DN3 cells showed 2.5-fold increase in stabilized ␤-catenin in the nucleus. Previous data had indicated that whereas ␤-catenin was expressed in RAG1-deficient DN thymocytes, no increase was documented upon anti-CD3 injection (17) . We also note no difference in the amount of stabilized ␤-catenin when we assay total cell lysates. In contrast, analysis of nuclear ␤-catenin shows a clearly measurable increase. Because ex vivo DN3 thymocytes express higher levels of ␤-catenin compared with DN4 thymocytes, these data suggest that pre-TCR signaled DN3 cells induce ␤-catenin stabilization before transition to the DN4 stage.
Pre-TCR signaling induced Erk activity was essential for ␤-catenin stabilization. We suggest that Erk mediated phosphorylation of GSK-3␤ at ser9 blocked phosphorylation and degradation of ␤-catenin (58), allowing its accumulation during ␤-selection. These data suggest regulation of ␤-catenin by pre-TCR signaling. In support of this notion, we demonstrate that anti-CD3 Ab mediated stimulation of BAT-lacZ reporter expressing DN thymocytes induced pre-TCR driven TCF activity. These observations are not congruent with the earlier observation that TCR-like signals stabilize ␤-catenin but do not induce TCF reporter activity in Jurkat cells (59) . We suggest that this is due to high levels of endogenous ␤-catenin expression in Jurkat cells making further up-regulation of TCF-reporter activity difficult to demonstrate. A role for Wnt1 and Wnt4 in DN thymocytes has been previously demonstrated (34) , suggesting the possibility that pre-TCR signals induce Wnt signaling, which then stabilizes ␤-catenin. Increased expression of target genes Id2 (data not shown) and p16 (54) also suggests enhanced ␤-catenin activity in DN thymocytes. Enforced expression of stabilized ␤-catenin induced several aspects of ␤-selection including down-regulation of CD25 and pre-T␣, and up-regulation of sterile TCR␣ transcript and Egr genes. These data indicate that ␤-catenin expression was sufficient to mediate essential aspects of ␤-selection. Therefore, we propose that pre-TCR induced ␤-catenin is required and sufficient to mediate some aspects of ␤-selection.
Egr proteins regulate ␤-selection (19, 22) . In particular, Egr3-deficient mice show a partial block at the DN3 stage of development (23) . In this report, we show that pre-TCR induced ␤-catenin regulates expression of Egr genes during ␤-selection. Retroviral expression of stabilized ␤-catenin was sufficient to induce Egr1 and 2 expression in Scid.adh cells. Accordingly, DN4 thymocytes from CAT-Tg mice showed increased expression of Egr genes whereas ex vivo CAT-KO DN4 thymocytes showed decreased expression of all three Egr genes. These data demonstrate that ␤-catenin expression regulated Egr gene expression in vivo. The finding that Egr genes contained consensus TCF binding sites that were conserved between human and mouse genes raised the possibility that ␤-catenin may directly regulate their transcription. Indeed, direct binding of ␤-catenin to the TCF binding sites was documented using ChIP and EMSA assays. TCF-reporter activity has been previously reported in DN3 thymocytes (17) raising the possibility that ␤-catenin and TCF/LEF may cooperatively regulate Egr expression. We propose that pre-TCR induced ␤-catenin cooperates with TCF to regulate Egr expression and facilitates ␤-selection. Finally, we tested whether Egr expression was sufficient to mediate traversal through ␤-selection by breeding Egr3-Tg mice with RAG2-deficient mice. Indeed, Egr3 expression was sufficient to efficiently regulate ␤-selection and facilitate the transition of DN3 cells to the DN4 stage. Therefore, we propose that pre-TCR induced ␤-catenin in cooperation with TCF regulate Egr gene expression and facilitates ␤-selection in vivo. In summary, data provided in this article demonstrate that pre-TCR induced ␤-catenin stabilization and nuclear localization regulates expression of Egr genes and thereby facilitates traversal through the ␤-selection checkpoint.
